These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485 [TBL] [Abstract][Full Text] [Related]
45. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam. Dasgupta S; Ray S; Dey S; Pal P; Mazumder B Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909 [TBL] [Abstract][Full Text] [Related]
46. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130 [TBL] [Abstract][Full Text] [Related]
47. Amphiphilic gels as a potential carrier for topical drug delivery. Prasad V; Kumar N; Mishra PR Drug Deliv; 2007 Feb; 14(2):75-85. PubMed ID: 17364871 [TBL] [Abstract][Full Text] [Related]
48. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis. Pradhan M; Singh D; Singh MR Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290 [TBL] [Abstract][Full Text] [Related]
49. Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles. Leung SS; Wong J; Guerra HV; Samnick K; Prud'homme RK; Chan HK AAPS J; 2017 Mar; 19(2):578-586. PubMed ID: 28070713 [TBL] [Abstract][Full Text] [Related]
50. Solid lipid nanoparticles for targeted delivery of triclosan into skin for infection prevention. Kakadia PG; Conway BR J Microencapsul; 2018; 35(7-8):695-704. PubMed ID: 30699002 [TBL] [Abstract][Full Text] [Related]
51. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097 [TBL] [Abstract][Full Text] [Related]
52. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization. Varia JK; Dodiya SS; Sawant KK Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553 [TBL] [Abstract][Full Text] [Related]
53. Topical delivery of Cyclosporine A into the skin using SPACE-peptide. Chen M; Kumar S; Anselmo AC; Gupta V; Slee DH; Muraski JA; Mitragotri S J Control Release; 2015 Feb; 199():190-7. PubMed ID: 25481447 [TBL] [Abstract][Full Text] [Related]
54. Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects. Siddique MI; Katas H; Jamil A; Mohd Amin MCI; Ng SF; Zulfakar MH; Nadeem SM Drug Deliv Transl Res; 2019 Apr; 9(2):469-481. PubMed ID: 29159691 [TBL] [Abstract][Full Text] [Related]
55. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin. Thakkar HP; Savsani H; Kumar P Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414 [TBL] [Abstract][Full Text] [Related]
56. Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. Pivetta TP; Simões S; Araújo MM; Carvalho T; Arruda C; Marcato PD Colloids Surf B Biointerfaces; 2018 Apr; 164():281-290. PubMed ID: 29413607 [TBL] [Abstract][Full Text] [Related]
57. Liposomal hydrogel formulation for transdermal delivery of pirfenidone. Jose A; Mandapalli PK; Venuganti VV J Liposome Res; 2016; 26(2):139-47. PubMed ID: 26114208 [TBL] [Abstract][Full Text] [Related]
58. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. Shrotriya SN; Ranpise NS; Vidhate BV Drug Deliv Transl Res; 2017 Feb; 7(1):37-52. PubMed ID: 27981502 [TBL] [Abstract][Full Text] [Related]
59. Recent advances in cyclosporine drug delivery: challenges and opportunities. Patel D; Wairkar S Drug Deliv Transl Res; 2019 Dec; 9(6):1067-1081. PubMed ID: 31144214 [TBL] [Abstract][Full Text] [Related]
60. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. Zhang J; Smith E J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]